MANAGE (MYCOPHENOLATE AWARENESS NETWORK: ASSISTANCE, GUIDANCE AND EDUCATION)

Serial Number 77630030
606

Registration Progress

Application Filed
Dec 10, 2008
Under Examination
Oct 27, 2009
Approved for Publication
Jul 15, 2009
Published for Opposition
Aug 4, 2009
Registered

Trademark Image

MANAGE (MYCOPHENOLATE AWARENESS NETWORK: ASSISTANCE, GUIDANCE AND EDUCATION)

Basic Information

Serial Number
77630030
Filing Date
December 10, 2008
Published for Opposition
August 4, 2009
Abandonment Date
May 28, 2012
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
May 28, 2012
Classes
016 044 045

Rights Holder

Hoffmann-La Roche Inc.

03
Address
340 Kingsland St.
Nutley, NJ 07110

Ownership History

Hoffmann-La Roche Inc.

Original Applicant
03
Nutley, NJ

Hoffmann-La Roche Inc.

Owner at Publication
03
Nutley, NJ

Legal Representation

Attorney
Lorraine M. Anderson

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

43 events
Date Code Type Description
May 29, 2012 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
May 28, 2012 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Nov 1, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 31, 2011 EX4G S SOU EXTENSION 4 GRANTED
Oct 26, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 26, 2011 EXT4 S SOU EXTENSION 4 FILED
Apr 28, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 27, 2011 EX3G S SOU EXTENSION 3 GRANTED
Apr 26, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 26, 2011 EXT3 S SOU EXTENSION 3 FILED
Oct 29, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 28, 2010 EX2G S SOU EXTENSION 2 GRANTED
Oct 25, 2010 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 25, 2010 EXT2 S SOU EXTENSION 2 FILED
May 8, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 7, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 6, 2010 EX1G S SOU EXTENSION 1 GRANTED
Apr 28, 2010 PROA I TEAS PETITION TO REVIVE RECEIVED
Apr 28, 2010 PETG O PETITION TO REVIVE-GRANTED
Apr 28, 2010 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION
Apr 27, 2010 EXT1 S SOU EXTENSION 1 FILED
Dec 11, 2009 CORV P REVIEW OF CORRESPONDENCE COMPLETE
Dec 9, 2009 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 6, 2009 MAIL I PAPER RECEIVED
Nov 5, 2009 FAXX I FAX RECEIVED
Oct 27, 2009 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Aug 4, 2009 PUBO A PUBLISHED FOR OPPOSITION
Jul 15, 2009 NPUB O NOTICE OF PUBLICATION
Jun 30, 2009 ALIE A ASSIGNED TO LIE
Jun 30, 2009 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 24, 2009 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 23, 2009 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jun 23, 2009 GNEA O EXAMINERS AMENDMENT E-MAILED
Jun 23, 2009 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 23, 2009 XAEC I EXAMINER'S AMENDMENT ENTERED
Jun 19, 2009 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 19, 2009 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 19, 2009 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 10, 2009 CNRT R NON-FINAL ACTION WRITTEN
Feb 10, 2009 GNRT F NON-FINAL ACTION E-MAILED
Feb 10, 2009 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 3, 2009 DOCK D ASSIGNED TO EXAMINER
Dec 16, 2008 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 016
booklets in the field of providing educational information to healthcare providers and female patients of childbearing potential of the risks associated with the use of mycophenolate-containing products during pregnancy and the appropriate steps to manage these risks
First Use Anywhere: 0
First Use in Commerce: 0
Class 044
providing educational information to healthcare providers and female patients of childbearing potential of the risks associated with the use of mycophenolate-containing products during pregnancy and the appropriate steps to manage these risks via an Internet website; maintaining a pregnancy registry for the purpose of documenting maternal and fetal outcomes in order to further characterize the risk of mycophenolate mofetil (MMF) / mycophenolic acid (MPA) fetal exposure
First Use Anywhere: 0
First Use in Commerce: 0
Class 045
administering a regulatory compliance program in the field of prescription medicine to prevent unplanned pregnancy and to provide pregnancy planning, thereby seeking to minimize and limit fetal exposure by informing healthcare providers and female patients of the risks associated with the use of mycophenolate-containing products during pregnancy and the appropriate steps to manage these risks
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
016 044 045

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"MYCOPHENOLATE AWARENESS NETWORK"

USPTO Documents

Loading USPTO documents...